Diagnostic evaluation of triple test in detection of breast lesions

Sanjay R. Gaikwad, Mahesh C. Talpallikar, Jyoti K. Tapadia, Anand S. Gajakos


Background: Detection of malignant lesion leads to early initiation of definitive treatment or its exclusion saves the patient from unnecessary medication and psychological trauma. It is difficult to establish the nature of the lesion merely on the clinical examination. So “triple” test is suggested, which is a mixture of clinical examination, mammography and FNAC.

Methods: The results of clinical examination, mammography and FNAC were compared with those of histopathological examination. The concordant results of the “triple test” were compared with those of the histopathological examination. Sensitivity, specificity, positive and negative predictive values were calculated for each of these tests and for “triple test”.

Results: The sensitivity, specificity, positive predictive value and negative predictive value of clinical examination in this study were 74.36%, 88.70%, 69.05% and 91.07%. The same parameters of mammography were 92.31%, 93.91%, 83.72% and 97.30%. For FNAC, the same values were 92.31%, 93.04%, 81.82% and 97.27%. The triple test was concordant in 115 lesions, while results of 39 lesions were discordant in triple test. Out of 115 concordant results, 27 results were malignant on all the three tests while 88 results were benign on all the three tests. All the concordant results of triple test were similar to the results of histopathology examination.

Conclusions: The triple test can diagnose malignant breast lesion with 100 % accuracy, at least in concordant results.


Breast lesions, FNAC, Mammography, Triple test

Full Text:



Barton MB, Harris R. The rational clinical examination. Does this patient have Breast cancer. The screening clinical examination: Should it be done? How? JAMA. 1999;282:1270-80.

Graf O, Herbich TH. Follow up of palpable circumscribed noncalcified solid breast masses at mammography and ultrasound. Can biopsy be averted? Radiol. 2004;233:850-56.

Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y, et al. A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. Ann Surg Oncol. 2013 Mar; 20:850-5.

Westenend PJ, Sever AR, Beekman‐de Volder HJ, Liem SJ. A comparison of aspiration cytology and core needle biopsy in the evaluation of breast lesions. Cancer Cytopathol. 2001 Apr 25;93(2):146-50.

Kharkwal S, Sameer AM. Triple test in carcinoma breast. J Clin Diag Res. 2014 Oct;8(10):NC09.

Sheikh MA, Akhtar J, Batool T, Naqvi R, Taqvi R, Jalil S, et al. A study of ovarian lesions in pre menarche girls. J Coll Physicians Surg Pak. 2007 Mar 1;17:162-5.

Vetto J, Pommier R, Schmidt W, Wachtel M, DuBois P, Jones M, Thurmond A. Use of the “triple test” for palpable breast lesions yields high diagnostic accuracy and cost savings. Am J Surg. 1995 May 1;169(5):519-22.

Ashley S, Royle GT, Corder A, Herbert A, Guyer PB, Rubin CM, Taylor I. Clinical, radiological and cytological diagnosis of breast cancer in young women. Br J Surg. 1989 Aug;76(8):835-7.

Khoda L, Kapa B, Singh KG, Gojendra T, Singh LR, Sharma KL. Evaluation of modified triple test (clinical breast examination, ultrasonography, and fine-needle aspiration cytology) in the diagnosis of palpable breast lumps. J Med Soc. 2015;29:26-30.

Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y et al. A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy Ann Surg Oncol. 2013 Mar;20:850-5.

McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012 Oct 15;22(3):276-82.

Johansen CA. Clinical study with special reference to diagnostic procedures. Acta Clin Scand. 1975;451 (suppl):1-70.

Morris KT, Pommier RF, Morris A, Schmidt WA, Beagle G, Alexander PW, et al. Usefulness of the triple test score for palpable breast masses. Archives of Surgery. 2001 Sep 1;136(9):1008-13.

Papeix G, Zardawi IM, Douglas CD, Clark DA, Braye SG. The accuracy of the ‘triple test’in the diagnosis of papillary lesions of the breast. Acta Cytologica. 2012;56(1):41-6.

Kachewar SS, Dongre SD. Role of triple test score in the evaluation of palpable breast lump. Indian J Med Paediatr Oncol. 2015 Apr;36(2):123-7.

Ahmed I, Nazir R, Choudhary MV, Kundi S. Triple assessment of breast Lump. J Cole physicians Surg Pak. 2007;17(9):535-38.

Mahsud ZS, Gul S. Diagnostic accuracy of mammography in clinically palpable breast lump. Pak J Radiol. 2003;14(2):5-8.

Thapa SB, Singh Y. Mammographic diagnosis of breast carcinoma: an institutional experience. J Nepal Med Assoc. 2008;47(170):62-5.

Medina-Franco H, Abarca-Pérez L, Cortés-González R, Soto-Germes S, Ulloa JA, Uribe N. Fine needle aspiration biopsy of breast lesions: institutional experience. J Clin Res.2005;57(3):394-8.